Patient, prescriber, and community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18 - Stein BD, Jones CM, Smart R, Sheng F, Sorbero M.
BACKGROUND: Prescribing naloxone to patients at increased opioid overdose risk is a key component of opioid overdose prevention efforts, but little is known about naloxone fills among patients receiving buprenorphine for opioid use disorder, one such high ... (Source: SafetyLit)
Source: SafetyLit - February 15, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS Patient Care - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS Administration and Leadership - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS Latest News - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS: Journal of Emergency Medical Services News - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS Operations - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
International Prehospital Medicine Institute Literature Review, January 2021
This study compares the 10-g AC to the 14-g AC for decompression of a tPTX and rescue from a tension-induced pulseless electrical activity (tPEA) in the setting of 30% estimated blood volume loss without hemothorax. The authors hypothesized the 10-g AC would be more effective and have a faster rescue from tension physiology than the 14-g AC currently used by most EMS systems.
This was an animal study utilizing anesthetized pigs. The researchers placed arterial and venous lines for hemodynamic monitoring. They then placed 12-mm trocars through each diaphragm through which they could infuse carbon dioxide to simulate a te...
Source: JEMS Special Topics - January 1, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives International Prehospital Medicine Institute Source Type: news
An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: a per-protocol and completers analysis - Mitchell MM, Schwartz RP, Choo TH, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J.
BACKGROUND: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes.
METHODS: We conducted a secondary analysis of... (Source: SafetyLit)
Source: SafetyLit - December 25, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Former Medical Director of Suboxone Manufacturer Indivior Sentenced in Connection with Drug Safety Claims
FDA OCI, Suboxone Film, Indivior, medical director, sentence, drug safety, claims, Timothy Baxter, marketing, opioid, drug, Massachusetts Medicaid, recovering addicts, misbranded drug, MassHealth, false, misleading, information, accidental, pediatric, exposure, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 18, 2020 Category: Medical Law Authors: DOJ Source Type: news
Reckitt Benckiser files £1bn claim against former subsidiary Indivior
Claim relates to US settlement over past marketing of opioid addiction treatment Suboxone (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 27, 2020 Category: Pharmaceuticals Source Type: news
Indivior Solutions Sentenced as Part of $2 Billion Resolution of False Safety Claims Concerning Suboxone
FDA OCI, Indivior, Suboxone, sentence, $2 billion restitution, false safety claims, criminal penalties marketing, false statements, health care, sales force, disbanded, Shaun Thaxter, Tim Baxter, misleading data, false data, pediatric exposure, prison sentence, CEO, MassHealth, Reckitt Benckiser, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - November 17, 2020 Category: Medical Law Authors: DOJ Source Type: news
Suboxone Manufacturer Indivior's Former Chief Executive Officer Sentenced to Jail Time in Connection with Drug Safety Claims
FDA OCI, Suboxone, CEO, Indivior, CEO, sentence, jail, drug safety claims, Shaun Thaxter, 6 months jail, misbranded drug, Suboxone Film, Reckitt Benckiser, opioid, buprenorphine, addiction treatment, false, misleading, safety information, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 27, 2020 Category: Medical Law Authors: DOJ Source Type: news
Suboxone Manufacturer Indivior's Former Chief Executive Officer Sentenced to Jail Time in Connection with Drug Safety Claims
FDA OCI, Suboxone, CEO, Indivior, CEO, sentence, jail, drug safety claims, Shaun Thaxter, 6 months jail, misbranded drug, Suboxone Film, Reckitt Benckiser, opioid, buprenorphine, addiction treatment, false, misleading, safety information, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 27, 2020 Category: Medical Law Authors: DOJ Source Type: news
Hudson Woman Pleads Guilty to Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, tampering, pharmacy technician, Nashua NH, prescription delivery, missing pills, oxycodone, opioids, different sizes, different imprints, baclofen, Suboxone, theft, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 21, 2020 Category: Medical Law Authors: DOJ Source Type: news
Opioid Manufacturer Indivior ’s Former Global Medical Director Pleads Guilty in Connection with Drug Safety Claims
FDA OCI, opioid, Indivior, director, guilty plea, drug safety claims, Timothy BAXTER, Suboxone Film, misdemeanor, misbranded drug, top medical executive, Reckitt Benckiser Pharmaceuticals, global medical director, $600 million, criminal liability, civil liability, opioid recovery, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - September 8, 2020 Category: Medical Law Authors: DOJ Source Type: news
